A multi-centre observational study of relapsing-remitting multiple sclerosis (RRMS) treated with first disease modifying therapies (DMTs) in current UK clinical practice: patterns of clinical decision making and the patient experience of relapse
100 项与 Novartis Pharmaceuticals (HK) Ltd. 相关的临床结果
0 项与 Novartis Pharmaceuticals (HK) Ltd. 相关的专利(医药)
100 项与 Novartis Pharmaceuticals (HK) Ltd. 相关的药物交易
100 项与 Novartis Pharmaceuticals (HK) Ltd. 相关的转化医学